PATENT CLAIM ANALYSIS

Application Number: 15747360
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "020100"]

Abstract:
The present invention provides methods of treating an immune system dysfunction or conditions associated with soluble BCMA using gamma secretase modulators or inhibitors in order to both restore immune function and improve the efficacy of therapies directed against BCMA present on the pathogenic B cell.

Claim (Index 10):
The method of  claim 1 , wherein the B cell condition or disorder is an autoimmune disease.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12450131', '11822419', '13357452', '12733339', '12943666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7618658067740168
- 35 USC 102 Novelty (BERT): 0.5323203899555361
- Combined Prediction Score: 0.7389112650921688
- Mean Citation Score: 305.050688
- Max Citation Score: 330.58286
- Similarity Product: 232.0165645597553

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test